Technical Analysis for ASMB - Assembly Biosciences, Inc.

Grade Last Price % Change Price Change
D 15.02 -2.09% -0.32
ASMB closed down 2.09 percent on Wednesday, November 20, 2024, on 61 percent of normal volume. It was able to bounce off of its 200 day moving average, an important long-term support line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
200 DMA Support Bullish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness -2.09%
BB Squeeze Ended Range Expansion -2.09%
Below Lower BB Weakness -2.09%
Down 3 Days in a Row Weakness -2.09%

   Recent Intraday Alerts

Alert Time
200 DMA Support about 17 hours ago
Down 3% about 17 hours ago
Down 2 % about 18 hours ago
Possible NR7 about 18 hours ago
60 Minute Opening Range Breakdown about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Assembly Biosciences, Inc. Description

Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gastrointestinal Gastroenterology Digestive System Surgery Digestive System Phenylephrine Fecal Incontinence Gastrointestinal Products

Is ASMB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.93
52 Week Low 8.2176
Average Volume 31,449
200-Day Moving Average 14.65
50-Day Moving Average 16.63
20-Day Moving Average 16.63
10-Day Moving Average 16.34
Average True Range 1.04
RSI (14) 37.50
ADX 18.19
+DI 15.42
-DI 20.51
Chandelier Exit (Long, 3 ATRs) 14.87
Chandelier Exit (Short, 3 ATRs) 17.73
Upper Bollinger Bands 17.89
Lower Bollinger Band 15.38
Percent B (%b) -0.14
BandWidth 15.09
MACD Line -0.26
MACD Signal Line -0.04
MACD Histogram -0.2196
Fundamentals Value
Market Cap 988.22 Million
Num Shares 65.8 Million
EPS -17.16
Price-to-Earnings (P/E) Ratio -0.88
Price-to-Sales 3.96
Price-to-Book 19.12
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.13
Resistance 3 (R3) 16.11 15.73 15.95
Resistance 2 (R2) 15.73 15.44 15.74 15.88
Resistance 1 (R1) 15.37 15.27 15.18 15.39 15.82
Pivot Point 14.99 14.99 14.89 15.00 14.99
Support 1 (S1) 14.63 14.70 14.44 14.65 14.22
Support 2 (S2) 14.25 14.53 14.26 14.16
Support 3 (S3) 13.89 14.25 14.10
Support 4 (S4) 13.91